Related Experiment Video
Updated: Jun 6, 2025
Preparation of Herbal Medicine: Er-Xian Decoction and Er-Xian-containing Serum for In Vivo and In Vitro Experiments
Published on: May 31, 2017
A review on the treatment of hyperlipidemia with Erchen Decoction
Xinyang Tian1, Peiyu Liu2, Ruolin Wang3
1Institute of Traditional Chinese Medicine Literature and Culture, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
Insights
Erchen Decoction (ECD) shows promise as an alternative treatment for hyperlipidemia (high cholesterol/triglycerides). This review explores its clinical use, mechanisms, and safety, offering insights for managing cardiovascular disease risk.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Traditional Chinese Medicine
Background:
- Hyperlipidemia, or dyslipidemia, involves elevated cholesterol and triglycerides, significantly increasing cardiovascular disease mortality.
- Statins are primary treatments but have side effects, driving demand for alternative therapies.
- Traditional Chinese Medicine (TCM) offers potential alternatives for managing dyslipidemia.
Purpose of the Study:
- To review current clinical research on Erchen Decoction (ECD) for hyperlipidemia.
- To elucidate the mechanisms of action of ECD in managing dyslipidemia.
- To assess the safety and compatibility of ECD in clinical practice.
Main Methods:
- Systematic review of clinical studies on Erchen Decoction for hyperlipidemia.
- Analysis of proposed pharmacological mechanisms of action.
- Evaluation of reported side effects and drug interactions.
Main Results:
- Summary of clinical evidence supporting ECD's efficacy in lowering lipid levels.
- Identification of key pathways targeted by ECD, such as lipid metabolism and inflammation.
- Assessment of ECD's safety profile and potential for integration with conventional treatments.
Conclusions:
- Erchen Decoction presents a promising complementary or alternative therapeutic option for hyperlipidemia.
- Further research is warranted to fully establish ECD's role in cardiovascular disease prevention and management.
- ECD's integration into clinical practice requires careful consideration of its mechanisms and safety data.
Abstract:
Hyperlipidemia, commonly referred to as dyslipidemia, is characterized by elevated serum cholesterol and/or triglyceride levels. This condition contributes significantly to the high mortality rates associated with cardiovascular diseases, posing a serious threat to global health. Although statins remain the predominant pharmacological treatment for hyperlipidemia, their associated side effects have led to a growing interest in alternative therapeutic approaches. Traditional Chinese Medicine (TCM) is exploring these alternatives, with the Erchen Decoction (ECD) emerging as a promising candidate. This review aims to summarize current clinical research, elucidate the mechanisms of action, and assess the compatibility of ECD in the management of hyperlipidemia. By doing so, we hope to provide valuable insights and references for clinical practice and future research.
More Related Videos
Related Concept Videos
01:26Endoscopic Procedures V: ERCP
Patient...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents